• 1
    Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:12811357.
  • 2
    Parati G, Ochoa JE, Lombardi C, et al. Assessment and management of blood pressure variability. Nat Rev Cardiol. 2013;10:143155.
  • 3
    Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895905.
  • 4
    Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit-to-visit variability in systolic blood pressure and all cause mortality in the general population. Findings from NHANES III, 1988 to 1994. Hypertension. 2011;57:160166.
  • 5
    Hata J, Arima H, Rothwell PM, et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus. The ADVANCE trial. Circulation. 2013;128:13251344.
  • 6
    Hastie CE, Jeemon P, Coleman H, et al. Long-term and ultra long-term blood pressure variability during follow-up and mortality in 14522 patients with hypertension. Hypertension. 2013;62:698705.
  • 7
    Kostis J, Sedjro J, Cabrera J, et al. Visit-to visit blood pressure variability and cardiovascular death in the Systolic Hypertension in the Elderly Program. J Clin Hypertens (Greenwich). 2013; DOI: 10.1111/jch.12230.
  • 8
    Muntner P, Levitan EB, Joyce C, et al. Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure. J Clin Hypertens (Greenwich). 2013;15:112117.
  • 9
    Mancia G. Prognostic value of long-term blood pressure variability: the evidence is growing. Hypertension. 2011;57:141143.
  • 10
    Smith TR, Drozda JP, Vanslette JA, et al. Medication class effects on visit-to-visit variability of blood pressure measurements: analysis of electronic health record data in the “real world.” J Clin Hypertens (Greenwich). 2013;15:655662.